Advertisements



We are Sorry, This Page doesn't Exist


ZIOPHARM Oncology, Inc. (ZIOP) CEO Dr. Laurence Cooper on Q3 2019 Results - Earnings Call Transcript

ZIOPHARM Oncology, Inc. (ZIOP) CEO Dr. Laurence Cooper on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 10th, 2019

ZIOPHARM Oncology Becomes Oversold (ZIOP)

Dividend Channel.....»»

Category: topSource: redinewsSep 24th, 2019

ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q2 2019 Results - Earnings Call Transcript

ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q2 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 8th, 2019

March 2021 Options Now Available For ZIOPHARM Oncology (ZIOP)

Stock Options Channel.....»»

Category: topSource: redinewsJun 21st, 2019

ZIOPHARM Oncology (ZIOP) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow

ZIOPHARM Oncology (ZIOP) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow.....»»

Category: topSource: seekingalphaJun 7th, 2019

ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q1 2019 Results - Earnings Call Transcript

ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q1 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 8th, 2019

Ziopharma"s Lead Asset Snags Fast Track Designation For Cancer Treatment

ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) shares were seeing activity Monday after the thinly traded small biotech announced that it secured a Fast Track designation for its lead asset. read more.....»»

Category: blogSource: benzingaApr 1st, 2019

Exclusive: Ziopharm Oncology CEO Wants To Disrupt The CAR-T Supply Chain

Ziopharm Oncology Inc. (NASDAQ: ZIOP) has two goals. One is to disrupt the narrative around recurrent glioblastomas. The other is to disrupt the entire pharmaceutical supply chain. read more.....»»

Category: blogSource: benzingaApr 16th, 2018

ZIOPHARM Oncology"s (ZIOP) CEO Laurence Cooper on Q1 2018 Results - Earnings Call Transcript

ZIOPHARM Oncology"s (ZIOP) CEO Laurence Cooper on Q1 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 10th, 2018

ZIOPHARM Oncology Breaks Above 200-Day Moving Average - Bullish for ZIOP

Market News Video.....»»

Category: topSource: redinewsMay 30th, 2018

Ziopharm Oncology shares slide 7% premarket after FDA places clinical hold on cancer trial

Ziop.....»»

Category: topSource: marketwatchJun 18th, 2018

ZIOPHARM Oncology"s (ZIOP) CEO Laurence Cooper on Q2 2018 Results - Earnings Call Transcript

ZIOPHARM Oncology"s (ZIOP) CEO Laurence Cooper on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 8th, 2018

Ziopharm Oncology (ZIOP) Q3 Earnings Preview: What"s Shaping Up?

Ziopharm (ZIOP) doesn't possess the rig.....»»

Category: personnelSource: nytOct 29th, 2018

ZIOPHARM Oncology"s (ZIOP) CEO Laurence Cooper on Q3 2018 Results - Earnings Call Transcript

ZIOPHARM Oncology"s (ZIOP) CEO Laurence Cooper on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 12th, 2018

Ziopharm Oncology (ZIOP) Reports Q3 Loss, Lags Revenue Estimates

Ziopha.....»»

Category: dealsSource: nytNov 13th, 2018

Do Hedge Funds Love ZIOPHARM Oncology Inc. (ZIOP)?

Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief.....»»

Category: topSource: insidermonkeyDec 23rd, 2018

Ziopharm Oncology (ZIOP) in Focus: Stock Moves 6.2% Higher

Ziopharm Oncology (ZIOP) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the .....»»

Category: worldSource: nytDec 28th, 2018

ZIOPHARM Oncology (ZIOP) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

ZIOPHARM Oncology (ZIOP) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow.....»»

Category: topSource: seekingalphaJan 11th, 2019

Jushi Holdings Q1 2024: Cannabis Gross Margin Climbs To 49.4%, Net Loss Widens To $18.4M

Jushi Holdings Inc. (OTC: JUSHF), a leading multi-state cannabis operator, reported its financial outcomes Thursday for the first quarter of 2024, highlighting advancements in profitability and operational efficiency. read more.....»»

Category: blogSource: benzingaMay 9th, 2024

Elon Musk Issues Stark Warning Amid Rising National Debt: "...The Dollar Will Be Worth Nothing"

Elon Musk has voiced concerns about the future stability of the U.S. dollar, highlighting the escalating national debt as a potential catalyst for a looming economic crisis. read more.....»»

Category: blogSource: benzingaMay 3rd, 2024